18F-FDG/13N-ammonia cardiac PET findings in ATTR cardiac amyloidosis

Kathleen A. Young, Melissa Lyle, Andrew N. Rosenbaum, Ian C. Chang, Grace Lin, Melanie C. Bois, Omar F.Abou Ezzeddine, Hayan Jouni, Panithaya Chareonthaitawee, Suraj Kapa, Martha Grogan, Leslie T. Cooper, Lori Blauwet, John P. Bois

Research output: Contribution to journalArticlepeer-review

Abstract

18F-flurodeoxyglycose (FDG)/13N-ammonia positron emission tomography/computed tomography (PET/CT) is frequently utilized to evaluate cardiac sarcoidosis (CS) but findings can reflect other forms of myocardial inflammation or altered myocardial metabolic activity. Herein, we present five cases where cardiac PET findings suggested CS, but right ventricular endomyocardial biopsy samples revealed ATTR-type cardiac amyloidosis.

Original languageEnglish (US)
JournalJournal of Nuclear Cardiology
DOIs
StateAccepted/In press - 2022

Keywords

  • ATTR cardiac amyloidosis
  • F-flurodeoxyglycose PET
  • Inflammation

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of '18F-FDG/13N-ammonia cardiac PET findings in ATTR cardiac amyloidosis'. Together they form a unique fingerprint.

Cite this